Dr. Hector Cott, MD

NPI: 1316014012
Total Payments
$3,848
2024 Payments
$350.10
Companies
9
Transactions
104

Payment Breakdown by Category

Food & Beverage$3,848 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,848 104 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,465 28 $0 (2024)
Sunovion Pharmaceuticals Inc. $1,231 36 $0 (2022)
ABBVIE INC. $409.55 12 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $345.09 13 $0 (2022)
Takeda Pharmaceuticals Puerto Rico LLC $161.22 9 $0 (2017)
Teva Pharmaceuticals USA, Inc. $124.08 1 $0 (2019)
Lundbeck LLC $46.46 2 $0 (2024)
E.R. Squibb & Sons, L.L.C. $44.58 2 $0 (2024)
Merck Sharp & Dohme Corporation $20.00 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $350.10 13 ABBVIE INC. ($238.11)
2023 $172.89 5 Janssen Pharmaceuticals, Inc ($101.45)
2022 $166.17 4 ABBVIE INC. ($100.00)
2021 $188.78 5 Janssen Pharmaceuticals, Inc ($129.17)
2020 $229.24 11 Sunovion Pharmaceuticals Inc. ($195.05)
2019 $827.55 18 Janssen Pharmaceuticals, Inc ($502.57)
2018 $1,037 25 Janssen Pharmaceuticals, Inc ($417.09)
2017 $875.98 23 Sunovion Pharmaceuticals Inc. ($452.22)

All Payment Transactions

104 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.02 General
Category: NEUROSCIENCE
11/26/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $19.58 General
11/13/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $25.00 General
09/17/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $23.23 General
Category: PSYCHIATRY
09/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.33 General
Category: NEUROSCIENCE
08/21/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $108.42 General
Category: NEUROSCIENCE
07/30/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $23.23 General
Category: PSYCHIATRY
06/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.44 General
Category: NEUROSCIENCE
05/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.30 General
Category: NEUROSCIENCE
05/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.22 General
Category: NEUROSCIENCE
04/02/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $20.95 General
Category: Neuroscience
03/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.12 General
Category: NEUROSCIENCE
01/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.26 General
Category: NEUROSCIENCE
11/21/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.64 General
Category: NEUROSCIENCE
09/05/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.00 General
Category: NEUROSCIENCE
06/20/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Neuroscience
02/28/2023 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $82.50 General
Category: Neuroscience
02/16/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.80 General
Category: NEUROSCIENCE
11/08/2022 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $28.67 General
Category: CNS
09/28/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $17.50 General
Category: Neuroscience
05/12/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $100.00 General
Category: NEUROSCIENCE
03/08/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.00 General
Category: NEUROSCIENCE
08/25/2021 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $37.50 General
Category: Neuroscience
08/24/2021 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $91.67 General
Category: Neuroscience
06/22/2021 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $15.61 General
Category: CNS

About Dr. Hector Cott, MD

Dr. Hector Cott, MD is a Psychiatry healthcare provider based in Guaynabo, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316014012.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Cott, MD has received a total of $3,848 in payments from pharmaceutical and medical device companies, with $350.10 received in 2024. These payments were reported across 104 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,848).

Practice Information

  • Specialty Psychiatry
  • Location Guaynabo, PR
  • Active Since 11/29/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1316014012

Products in Payments

  • LATUDA (Drug) $1,231
  • INVEGA SUSTENNA (Drug) $1,094
  • Trintellix (Drug) $466.31
  • VRAYLAR (Drug) $409.55
  • INVEGA (Drug) $211.67
  • ZYTIGA (Drug) $124.86
  • AUSTEDO (Drug) $124.08
  • REXULTI (Drug) $46.46
  • TRINTELLIX (Drug) $40.00
  • XARELTO (Drug) $34.70
  • BELSOMRA (Drug) $20.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Guaynabo